ANALYSIS OF CHROMOSOMAL-ABERRATIONS, SISTER-CHROMATID EXCHANGES AND MICRONUCLEI IN PERIPHERAL LYMPHOCYTES OF PHARMACISTS BEFORE AND AFTER WORKING WITH CYTOSTATIC DRUGS
S. Roth et al., ANALYSIS OF CHROMOSOMAL-ABERRATIONS, SISTER-CHROMATID EXCHANGES AND MICRONUCLEI IN PERIPHERAL LYMPHOCYTES OF PHARMACISTS BEFORE AND AFTER WORKING WITH CYTOSTATIC DRUGS, Mutation research. Mutation research letters, 325(4), 1994, pp. 157-162
The frequencies of chromosome aberrations, SCEs and micronuclei (cytok
inesis-block method) in blood lymphocytes were compared among six nons
moking female pharmacists before and after 1 year of working with cyto
static drugs. All possible precautions were taken to avoid exposure to
cytostatics, including proper protective clothing and a monitored, ne
gative-pressured working environment with vertical laminar flow cabine
t. As referents, an age-matched group of six nonsmoking female hospita
l workers not dealing with cytostatics was simultaneously sampled twic
e with the same time interval. The pharmacists showed a marginally hig
her mean frequency of SCEs/cell (6.3; P = 0.049) after the working per
iod than 1 year earlier (5.8). On the other hand, the referents, with
no obvious exposure, had a higher mean number of cells with chromatid-
type aberrations, gaps excluded, in the second sampling (2.0%; P=0.048
) than in the first one (0.5%). In addition, a slight (P=0.055) trend
towards a higher frequency of micronucleated binucleate cells was obse
rved in the second sampling for both the exposed and control subjects.
As such findings suggest technical variation in the cytogenetic param
eters, the small difference observed in SCEs for the pharmacists betwe
en the two samplings was probably not related to the cytostatics expos
ure. No statistically significant differences were observed for any of
the cytogenetic parameters in comparisons between the pharmacists and
the referents. The findings suggest that caution should be exercised
in comparing results obtained from two different samplings in prospect
ive cytogenetic studies.